Clinical trial
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
NCT02053493
Study timeline
Study start (unknown)2014-04-01Date precision: month
Registry last updated2016-11-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
Isosorbide MononitrateDRUG · verified · RxNorm: isosorbide mononitrate
PlaceboDRUG
Sponsors & collaborators
Mapped research locations
BostonMassachusetts, United States3PhiladelphiaPennsylvania, United States3ClevelandOhio, United States3Salt Lake CityUtah, United States2HoustonTexas, United States1ChicagoIllinois, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1DurhamNorth Carolina, United States1RochesterMinnesota, United States1NewarkDelaware, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02053493 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.